ORPHA:67038
B-cell chronic lymphocytic leukemia
Also known as: B-CLL · B-cell chronic lymphoid leukemia · CLL · CLL/SLL · Chronic lymphocytic leukemia · Small lymphocytic lymphoma
Publications
80,503
99.8th percentile
Trials
1,363
Interventional, condition-specific
Researchers
1,471
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
B-cell chronic lymphocytic leukemia (B-CLL) is a type of B-cell non-Hodgkin lymphoma, and the most common form of leukemia in Western countries, affecting elderly adults (mean age of 67 and 72 years) with a slight male predominance (1.7:1), and characterized by a highly variable clinical presentation that can include asymptomatic disease or non-specific B-symptoms such as unintentional weight loss, severe fatigue, fever (without evidence of infection), and night sweats as well as cervical lymphadenopathy, and frequent infections. Some patients can also develop autoimmune complications such as autoimmune hemolytic anemia or immune thrombocytopenia. The clinical course is extremely heterogeneous with survival ranging from a few months to several decades.
How rare: 1-5 / 10 000 — about one to five people per ten thousand (still uncommon, but less ultra-rare).
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0004948
- MeSH:D015451
- OMIM:151400
- UMLS:C0023434
- NCIT:C3163
Additional Mondo synonyms (24)
B cell CLL · B cell chronic lymphocytic leukaemia · B cell chronic lymphocytic leukemia · B cell lymphocytic leukaemia · B cell lymphocytic leukemia · B-cell CLL · B-cell chronic lymphogenous leukaemia · B-cell chronic lymphogenous leukemia · B-cell chronic lymphoid leukaemia · B-cell lymphocytic leukaemia · B-cell lymphocytic leukemia · BCLL · Chronic Lymphocytic Leukemia · chronic B-cell lymphocytic leukaemia · chronic B-cell lymphocytic leukemia · chronic lymphatic leukemia · chronic lymphocytic leukaemia (CLL) · chronic lymphocytic leukemia · chronic lymphocytic leukemia (CLL) · chronic lymphogenous leukaemia · chronic lymphogenous leukemia · hematopoeitic - chronic lymphocytic leukaemia (CLL) · hematopoeitic - chronic lymphocytic leukemia (CLL) · lymphoplasmacytic leukemia
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
80,503 matched papers (42,381 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
1,363 matched on ClinicalTrials.gov (182 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
80,503
80,503 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
80,503 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
42,381 in the last 10 years · medium confidence · 99.8th percentile (publications denominator)
Phrase hits: 80,494 · MeSH hits: 72
Who's working on it?
1,471
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01
- 02
- 03Qiu L6 papers · 2026
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, P.R. China.
Papers in Europe PMC - 04Wang Y6 papers · 2026
Department of Hematology,The Fifth Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Papers in Europe PMC - 05Shadman M5 papers · 2026
Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.
Papers in Europe PMC - 06Wierda WG5 papers · 2026
Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Papers in Europe PMC - 07Davids MS4 papers · 2026
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Papers in Europe PMC - 08Parikh SA4 papers · 2026
Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Papers in Europe PMC - 09Robak T4 papers · 2026
Department of Hematology, Medical University of Lodz, Lodz, Poland.
Papers in Europe PMC - 10Tam CS4 papers · 2026
Department of Haematology, Alfred Hospital, Melbourne, VIC, Australia; Haematology, Monash University, Melbourne, VIC, Australia.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
1,363
interventional trials for this specific condition
1,363 interventional trials matched this specific condition name; 182 currently recruiting in our sample.
Data as of 27 July 2026
1,363 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 99.9th percentile).
medium confidence · 99.9th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
1,363 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06475469·RECRUITING·Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
Conditions: Chronic Lymphocytic Leukemia·Matched via name phrase
- NCT06319456·RECRUITING·A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
Conditions: CLL/SLL·Matched via name phrase
- NCT05281809·RECRUITING·Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
Conditions: B-Cell Lymphoma · B Acute Lymphoblastic Leukemia · Diffuse Large B Cell Lymphoma · Mantle Cell Lymphoma·Matched via name phrase
- NCT07710781·NOT YET RECRUITING·Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
Conditions: Hematologic Malignancy · Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia·Matched via name phrase
- NCT03676504·RECRUITING·Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Conditions: Acute Lymphoblastic Leukemia, Adult · Acute Lymphoblastic Leukemia, Pediatric · Chronic Lymphocytic Leukemia · Diffuse Large B Cell Lymphoma·Matched via name phrase
- NCT06528301·RECRUITING·A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Conditions: Lymphoma, B-Cell · Lymphoma, Non-Hodgkin (NHL) · Lymphoma, Large B-Cell, Diffuse (DLBCL) · Chronic Lymphocytic Leukemia (CLL)·Matched via name phrase
- NCT03765177·RECRUITING·CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia · Non-Hodgkin's Lymphoma · Chronic Lymphocytic Leukemia·Matched via name phrase
- NCT04560322·RECRUITING·Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
Conditions: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma·Matched via name phrase
- NCT07218341·RECRUITING·A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia · Lymphoma, Small Lymphocytic·Matched via name phrase
- NCT06980116·RECRUITING·Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Conditions: Relapsed or Refractory B-cell Malignancies · Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) · Follicular Lymphoma (FL) · Marginal Zone Lymphoma (MZL)·Matched via name phrase
- NCT06043674·RECRUITING·Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Conditions: Chronic Lymphocytic Leukemia · Richter's Transformation·Matched via name phrase
- NCT06708897·RECRUITING·A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas
Conditions: CLL / SLL · CLL (Chronic Lymphocytic Leukemia) · SLL (Small Lymphocytic Lymphoma)·Matched via name phrase
- NCT03314974·RECRUITING·Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Conditions: Acute Leukemia · Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Lymphoma·Matched via name phrase
- NCT07690891·NOT YET RECRUITING·Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia·Matched via name phrase
- NCT06958705·RECRUITING·Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
Conditions: Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)·Matched via name phrase
Observational and natural-history studies
189 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07099443·RECRUITING·Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia · BTK Degraders·Matched via name phrase
- NCT06821880·RECRUITING·Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
Conditions: Chronic Lymphocytic Leukaemia (CLL) · Multiple Myeloma (MM) · Secondary Immunodeficiency (SID)·Matched via name phrase
- NCT05371808·RECRUITING·Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:
Conditions: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma·Matched via name phrase
- NCT07157579·NOT YET RECRUITING·Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
Conditions: Chronic Lymphocytic Leukemia (CLL)- Non-Hodgins's Lymphoma (NHL)·Matched via name phrase
- NCT06548152·RECRUITING·AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database
Conditions: Chronic Lymphocytic Leukemia·Matched via name phrase
- NCT07602088·RECRUITING·A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic Leukemia
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell·Matched via name + MeSH
- NCT03375619·RECRUITING·Long-term Follow-up Study of Patients Receiving CAR-T Cells
Conditions: Chronic Lymphocytic Leukemia · Lymphomas Non-Hodgkin's B-Cell · Lymphoma, Small Lymphocytic · Mantle Cell Lymphoma·Matched via name phrase
- NCT04028531·RECRUITING·Understanding Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia·Matched via name phrase
- NCT05246345·RECRUITING·Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia · CLL · Progressive Chronic Lymphocytic Leukemia · Refractory Chronic Lymphocytic Leukemia·Matched via name phrase
- NCT00923507·RECRUITING·Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Conditions: Waldenstrom Macroglobulinemia · Lymphoplasmacytic Lymphoma · Monoclonal B-Cell Lymphocytosis · Small Lymphocytic Lymphoma·Matched via name phrase
- NCT01087333·RECRUITING·Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Conditions: Hairy Cell Leukemia (HCL) · Chronic Lymphocytic Leukemia (CLL) · Non-Hodgkins Lymphoma (NHL) · Cutaneous T Cell Lymphoma (CTCL)·Matched via name phrase
- NCT05326308·RECRUITING·Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
Conditions: Waldenström's Macroglobulinemia · Chronic Lymphocytic Leukemia · Marginal Zone Lymphoma · Follicular Lymphoma·Matched via name phrase
- NCT06151730·RECRUITING·Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Conditions: Chronic Lymphocytic Leukemia · Hematopoietic and Lymphoid System Neoplasm · Mantle Cell Lymphoma · Marginal Zone Lymphoma·Matched via name phrase
- NCT06250465·RECRUITING·AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
Conditions: Chronic Lymphocytic Leukemia·Matched via name phrase
- NCT05334069·RECRUITING·Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Conditions: Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Ann Arbor Stage I Lymphoma · Ann Arbor Stage II Lymphoma·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"B-cell chronic lymphocytic leukemia" OR "B-CLL" OR "B-cell chronic lymphoid leukemia" OR "CLL/SLL" OR "Chronic lymphocytic leukemia" OR "Small lymphocytic lymphoma" OR "B cell CLL" OR "B cell chronic lymphocytic leukaemia" OR "B cell chronic lymphocytic leukemia" OR "B cell lymphocytic leukaemia" OR "B cell lymphocytic leukemia" OR "B-cell CLL" OR "B-cell chronic lymphogenous leukaemia" OR "B-cell chronic lymphogenous leukemia" OR "B-cell chronic lymphoid leukaemia" OR "B-cell lymphocytic leukaemia" OR "B-cell lymphocytic leukemia" OR "chronic B-cell lymphocytic leukaemia" OR "chronic B-cell lymphocytic leukemia" OR "chronic lymphatic leukemia" OR "chronic lymphocytic leukaemia (CLL)" OR "chronic lymphocytic leukemia (CLL)" OR "chronic lymphogenous leukaemia" OR "chronic lymphogenous leukemia" OR "hematopoeitic - chronic lymphocytic leukaemia (CLL)" OR "hematopoeitic - chronic lymphocytic leukemia (CLL)" OR "lymphoplasmacytic leukemia"
MeSH descriptor terms unioned into the query: Leukemia, Lymphocytic, Chronic, B-Cell
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"B-cell chronic lymphocytic leukemia" OR "B-CLL" OR "B-cell chronic lymphoid leukemia" OR "CLL/SLL" OR "Chronic lymphocytic leukemia" OR "Small lymphocytic lymphoma" OR "B cell CLL" OR "B cell chronic lymphocytic leukaemia" OR "B cell chronic lymphocytic leukemia" OR "B cell lymphocytic leukaemia" OR "B cell lymphocytic leukemia" OR "B-cell CLL" OR "B-cell chronic lymphogenous leukaemia" OR "B-cell chronic lymphogenous leukemia" OR "B-cell chronic lymphoid leukaemia" OR "B-cell lymphocytic leukaemia" OR "B-cell lymphocytic leukemia" OR "chronic B-cell lymphocytic leukaemia" OR "chronic B-cell lymphocytic leukemia" OR "chronic lymphatic leukemia" OR "chronic lymphocytic leukaemia (CLL)" OR "chronic lymphocytic leukemia (CLL)" OR "chronic lymphogenous leukaemia" OR "chronic lymphogenous leukemia" OR "hematopoeitic - chronic lymphocytic leukaemia (CLL)" OR "hematopoeitic - chronic lymphocytic leukemia (CLL)" OR "lymphoplasmacytic leukemia" OR "Leukemia, Lymphocytic, Chronic, B-Cell"
Interventional trials matched via: both, phrase, mesh (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 1363 interventional · 189 observational · 5 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: CLL; BCLL
Confidence reasoning
- Preferred label is multi-word and distinctive
- 2 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T01:24:38.050Z
